P230021/S004: Duo Venous Stent System
FDA’s recorded scope: changes to the nitinol material and supplier
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 4 FDA records to the applicant name Philips Image Guided Therapy Corporation. The collection includes 1 510(k) clearance. 2 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Nov 18, 2025 to Aug 26, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QAN appears in 3 of the 4 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P230021, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 5905 Nathan Ln. N., Plymouth, MN, 55442. Recorded on P230021/S004, decision dated Aug 26, 2026.
Stent, Iliac Vein; System, Imaging, Pulsed Echo, Ultrasonic.
FDA’s recorded scope: changes to the nitinol material and supplier
FDA’s recorded scope: Approval of the updated Instruction for Use for both the Duo Venous Stent System (Pin/Pull delivery system) and Duo Venous Stent System (Triaxial Handle delivery system) with final results of the VIVID study.
FDA’s recorded scope: Approval for a design ownership and legal manufacturer located at Philips Image Guided Therapy Corporation (Philips), 5905 Nathan Lane North, Plymouth, MN 55442 and 9965 Federal Drive, Colorado Springs, CO 80921 USA
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Volcano Corp | Class II | Oct 7, 2026 | FDA |
Z-3276-2026 · FDA links K253714 · Recalling firm: Volcano Corp
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Duo Venous Stent SystemP230021/S004 | Philips Image Guided Therapy Corporation | PMA supplement | Aug 26, 2026 | FDA |
IntraSight PlusK253714 | Philips Image Guided Therapy Corporation | 510(k) clearance | Feb 24, 2026 | FDA |
Duo Venous Stent SystemP230021/S003 | Philips Image Guided Therapy Corporation | PMA supplement | Feb 12, 2026 | FDA |
Duo Venous Stent SystemP230021/S002 | Philips Image Guided Therapy Corporation | PMA supplement | Nov 18, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.